Minerva Neurosciences, Inc.

NERV

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001598646

SEC filings (opens in a new tab)

No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Minerva Neurosciences, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of NERV: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	17	19	+2
Shares	1.68M	2.35M	+671.2K (+39.9%)
Value	$2.69M	$19.0M	+$16.4M (+608.6%)

New holders (3)

Institutions that held Minerva Neurosciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to NERV in Q2 2023
Institution	Shares	Value	% of portfolio
FMR LLC	491,746	$4.49M	0.00%
Virtu Financial LLC	20,993	$192.0K	0.01%
UBS Group AG	434	$3.97K	0.00%

Sold out (1)

Institutions that held Minerva Neurosciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of NERV in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Belpointe Asset Management LLC	100	$160